Tether (CRYPTO:USDT) is expected to end 2024 with net profits exceeding $10 billion, according to its CEO, Paolo Ardoino. Over the course of the year, Tether’s market valuation grew by around $50 ...

GenusPlus Group (ASX:GNP), a provider of essential power and communications infrastructure, has been awarded a contract for Stage 1 of the North West Transmission Developments Project by TasNetworks.

Bitcoin's (CRYPTO:BTC) price shows signs of a possible deeper correction after it failed to sustain the $100,000 level, with analysts suggesting that a decline to the $80,000 support zone may be on ...

Australia's consumer price index for November 2024 increased by 2.3%, a slight uptick from the 2.1% rise recorded for October 2024, according to the latest data from the Australian Bureau of ...

Viva Energy Group (ASX:VEA) has reported that its Geelong Refinery experienced an unscheduled shutdown on Jan. 12. The incident resulted from an external power supply interruption during a lightning ...

Sigma Lithium Corporation (NASDAQ:SGML) surpassed its production targets in the fourth quarter of 2024, producing 75,000 tonnes of Quintuple Zero Green Lithium. This achievement brings the total ...

Electric vehicle manufacturer Rivian (NASDAQ:RIVN) surpassed analysts' expectations for fourth-quarter deliveries, signaling a strong recovery from a component shortage that had constrained its ...

AVITA Medical (ASX:AVH) announced that the US Food and Drug Administration has approved its RECELL GO mini. This new product is an extension of the RECELL GO system, designed specifically to optimise ...

Novonix (ASX:NVX) has entered into an exclusive licensing agreement with long-time technology partner, Harper International Corporation. The agreement grants Novonix the rights to Harper's continuous, ...

Blockchain investigator ZachXBT has exposed a phishing operation targeting Solana (CRYPTO:SOL) meme coin investors, resulting in losses of approximately $500,000. The scheme compromised over 15 ...

Arovella Therapeutics (ASX:ALA), a biotechnology company in cancer immunotherapy, has announced securing $20 million through a share placement. The funds are earmarked for a Phase 1 clinical trial of ...